摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-methoxy-6-methyl-1,2,4-benzotriazin-3-amine 1-oxide | 763132-05-4

中文名称
——
中文别名
——
英文名称
7-methoxy-6-methyl-1,2,4-benzotriazin-3-amine 1-oxide
英文别名
7-Methoxy-6-methyl-1-oxido-1,2,4-benzotriazin-1-ium-3-amine
7-methoxy-6-methyl-1,2,4-benzotriazin-3-amine 1-oxide化学式
CAS
763132-05-4
化学式
C9H10N4O2
mdl
——
分子量
206.204
InChiKey
DHEIMKZTPJULIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >320 °C(Solv: methanol (67-56-1))
  • 沸点:
    453.6±37.0 °C(Predicted)
  • 密度:
    1.47±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    86.5
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Stille Coupling Reactions in the Synthesis of Hypoxia-Selective 3-Alkyl-1,2,4-Benzotriazine 1,4-Dioxide Anticancer Agents
    摘要:
    The introduction of a 3-alkyl substituent is a key step in the synthesis of 1,2,4-benzotriazine 1,4-dioxide hypoxia-selective anticancer agents, such as SN29751. The Stille reaction of 3-chloro-1,2,4-benzotriazine 1-oxides ( BTOs) 5 was inhibited by the presence of electron donating substituents on the benzo ring, thus limiting the range of compounds available for SAR studies. The use of 3-iodo-BTOs 8 did not provide a significant improvement in the yields of 3-ethyl-BTOs 6. Microwave-assisted Stille coupling of chlorides 5 gave dramatically improved yields, which were consistently superior to those from the corresponding iodides 8. The application of microwave-assisted synthesis extended the range of substituted BTOs available for SAR studies and provided an efficient, scalable synthesis of the investigational anticancer agent, SN29751 ( 1).
    DOI:
    10.1021/jo060986g
  • 作为产物:
    描述:
    氰胺2-硝基-4-甲氧基-5-甲基苯胺盐酸sodium hydroxide 作用下, 以 为溶剂, 反应 7.0h, 以97%的产率得到7-methoxy-6-methyl-1,2,4-benzotriazin-3-amine 1-oxide
    参考文献:
    名称:
    Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
    摘要:
    本发明涉及一种协同组合物,包括一种或多种苯并噁唑-单-N-氧化物,以及一种或多种苯并噁唑1,4-二氧化物,用于癌症治疗。 该发明还提供了一系列新颖的1,2,4苯并噁唑-单-N-氧化物及相关类似物。这些可以用作增强现有抗癌药物的细胞毒性和癌症治疗的治疗剂。
    公开号:
    EP1468688A2
点击查看最新优质反应信息

文献信息

  • Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
    申请人:Auckland Uniservices Limited
    公开号:EP1468688A2
    公开(公告)日:2004-10-20
    The present invention relates to a synergetistic composition comprising one or more benzoazine-mono-N-oxides, and one or more benzoazine 1,4 dioxides for use in cancer therapy. The invention also provides a range of novel 1,2,4 benzoazine-mono-N-oxides and related analogues. These can be used as potentiators of the cytotoxicity of existing anticancer drugs and therapies for cancer treatment.
    本发明涉及一种协同组合物,包括一种或多种苯并噁唑-单-N-氧化物,以及一种或多种苯并噁唑1,4-二氧化物,用于癌症治疗。 该发明还提供了一系列新颖的1,2,4苯并噁唑-单-N-氧化物及相关类似物。这些可以用作增强现有抗癌药物的细胞毒性和癌症治疗的治疗剂。
  • Stille Coupling Reactions in the Synthesis of Hypoxia-Selective 3-Alkyl-1,2,4-Benzotriazine 1,4-Dioxide Anticancer Agents
    作者:Karin Pchalek、Michael P. Hay
    DOI:10.1021/jo060986g
    日期:2006.8.1
    The introduction of a 3-alkyl substituent is a key step in the synthesis of 1,2,4-benzotriazine 1,4-dioxide hypoxia-selective anticancer agents, such as SN29751. The Stille reaction of 3-chloro-1,2,4-benzotriazine 1-oxides ( BTOs) 5 was inhibited by the presence of electron donating substituents on the benzo ring, thus limiting the range of compounds available for SAR studies. The use of 3-iodo-BTOs 8 did not provide a significant improvement in the yields of 3-ethyl-BTOs 6. Microwave-assisted Stille coupling of chlorides 5 gave dramatically improved yields, which were consistently superior to those from the corresponding iodides 8. The application of microwave-assisted synthesis extended the range of substituted BTOs available for SAR studies and provided an efficient, scalable synthesis of the investigational anticancer agent, SN29751 ( 1).
查看更多